Benjamin Burnett
Stock Analyst at Stifel
(2.19)
# 1,502
Out of 4,479 analysts
56
Total ratings
44.19%
Success rate
-5.66%
Average return
Main Sectors:
Top Industries:
17 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IDYA IDEAYA Biosciences | Maintains: Buy | $55 → $63 | $35.92 | +75.39% | 5 | Jun 4, 2024 | |
| PGEN Precigen | Maintains: Buy | $7 → $10 | $1.55 | +545.16% | 3 | Jun 3, 2024 | |
| ACLX Arcellx | Maintains: Buy | $82 → $83 | $53.60 | +54.85% | 4 | May 15, 2024 | |
| ALLO Allogene Therapeutics | Maintains: Hold | $4.4 → $4.6 | $2.33 | +97.42% | 4 | May 14, 2024 | |
| IRON Disc Medicine | Maintains: Buy | $71 → $73 | $46.47 | +57.09% | 5 | Apr 8, 2024 | |
| ATRA Atara Biotherapeutics | Maintains: Hold | $4.8 → $2.3 | $8.36 | -72.49% | 2 | Apr 1, 2024 | |
| RPTX Repare Therapeutics | Maintains: Buy | $16 → $17 | $3.33 | +410.51% | 4 | Sep 25, 2023 | |
| RVMD Revolution Medicines | Maintains: Buy | $37 → $47 | $38.81 | +21.10% | 3 | Sep 21, 2023 | |
| IOVA Iovance Biotherapeutics | Reiterates: Buy | $25 | $8.06 | +210.17% | 9 | Sep 15, 2023 | |
| EFTR eFFECTOR Therapeutics | Upgrades: Buy | $33 → $175 | $0.27 | +65,467.63% | 4 | May 26, 2023 | |
| CRSP CRISPR Therapeutics AG | Maintains: Hold | $69 → $64 | $53.95 | +18.63% | 4 | May 9, 2023 | |
| FATE Fate Therapeutics | Maintains: Hold | $5.3 → $5 | $3.26 | +53.37% | 2 | May 4, 2023 | |
| DTIL Precision BioSciences | Maintains: Buy | $690 → $780 | $9.89 | +7,786.75% | 2 | Sep 10, 2021 | |
| NKTR Nektar Therapeutics | Upgrades: Buy | n/a | $1.22 | - | 2 | Jun 28, 2021 | |
| SGMO Sangamo Therapeutics | Initiates: Hold | n/a | $0.33 | - | 1 | Jan 6, 2021 | |
| BEAM Beam Therapeutics | Initiates: Hold | n/a | $23.05 | - | 1 | Jan 6, 2021 | |
| BLUE bluebird bio | Upgrades: Buy | n/a | $0.98 | - | 1 | Mar 27, 2020 |
IDEAYA Biosciences
Jun 4, 2024
Maintains: Buy
Price Target: $55 → $63
Current: $35.92
Upside: +75.39%
Precigen
Jun 3, 2024
Maintains: Buy
Price Target: $7 → $10
Current: $1.55
Upside: +545.16%
Arcellx
May 15, 2024
Maintains: Buy
Price Target: $82 → $83
Current: $53.60
Upside: +54.85%
Allogene Therapeutics
May 14, 2024
Maintains: Hold
Price Target: $4.4 → $4.6
Current: $2.33
Upside: +97.42%
Disc Medicine
Apr 8, 2024
Maintains: Buy
Price Target: $71 → $73
Current: $46.47
Upside: +57.09%
Atara Biotherapeutics
Apr 1, 2024
Maintains: Hold
Price Target: $4.8 → $2.3
Current: $8.36
Upside: -72.49%
Repare Therapeutics
Sep 25, 2023
Maintains: Buy
Price Target: $16 → $17
Current: $3.33
Upside: +410.51%
Revolution Medicines
Sep 21, 2023
Maintains: Buy
Price Target: $37 → $47
Current: $38.81
Upside: +21.10%
Iovance Biotherapeutics
Sep 15, 2023
Reiterates: Buy
Price Target: $25
Current: $8.06
Upside: +210.17%
eFFECTOR Therapeutics
May 26, 2023
Upgrades: Buy
Price Target: $33 → $175
Current: $0.27
Upside: +65,467.63%
CRISPR Therapeutics AG
May 9, 2023
Maintains: Hold
Price Target: $69 → $64
Current: $53.95
Upside: +18.63%
Fate Therapeutics
May 4, 2023
Maintains: Hold
Price Target: $5.3 → $5
Current: $3.26
Upside: +53.37%
Precision BioSciences
Sep 10, 2021
Maintains: Buy
Price Target: $690 → $780
Current: $9.89
Upside: +7,786.75%
Nektar Therapeutics
Jun 28, 2021
Upgrades: Buy
Price Target: n/a
Current: $1.22
Upside: -
Sangamo Therapeutics
Jan 6, 2021
Initiates: Hold
Price Target: n/a
Current: $0.33
Upside: -
Beam Therapeutics
Jan 6, 2021
Initiates: Hold
Price Target: n/a
Current: $23.05
Upside: -
bluebird bio
Mar 27, 2020
Upgrades: Buy
Price Target: n/a
Current: $0.98
Upside: -